Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07806149) titled 'NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Multi-Center Prospective Study Using Improvised Off-Label Devices' on Sept. 3.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Condition: Hypertrophic Cardiomyopathy Left Ventricular Outflow Obstruction Systolic Anterior Motion

Intervention: Device: SESAME Procedure

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: September 16, 2026

Target ...